Search Tag: cancer treatment
2024 15 Apr
GT Medical Technologies, Inc. (GT MedTech) announces the successful acquisition of Cesium-131 and related assets from Isoray Medical, a subsidiary of Perspective Therapeutics, Inc. This acquisition solidifies GT MedTech's position as sole manufacturer of Cesium-131 brachytherapy seeds for cancer treatments. The completion of the acquisition...Read more
2024 25 Oct
<marquee behavior="slide" direction="left" scrollamount="30"> <h2 style="text-align: center;"><font color="#000099"><b>Find ESMO On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://www.twitter.com/myesmo target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><Read more
2024 05 Mar
A pioneering platform has been developed by scientists from the National University of Singapore (NUS) and the National Cancer Centre Singapore (NCCS), aiming to dramatically reduce the duration required for assessing the effectiveness of cancer drugs. The study, published in Biomaterials utilises bioengineered hydrogels that mimic tissue. This...Read more
2024 05 Mar
A pioneering platform has been developed by scientists from the National University of Singapore (NUS) and the National Cancer Centre Singapore (NCCS), aiming to dramatically reduce the duration required for assessing the effectiveness of cancer drugs. The study, published in Biomaterials utilises bioengineered hydrogels that mimic tissue. This...Read more
2024 01 Mar
<marquee behavior="slide" direction="left" scrollamount="30"><h2 style="text-align: center;"><font color="#000099"><b> Find EORTC On Social Media </b> </font></h2><div style="text-align: center;"><a href=https://twitter.com/EORTC target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a>Read more
2023 13 Dec
A renowned expert in cardio-oncology and heart failure, Michelle Bloom, MD, has joined NYU Langone Health as system director of the Cardio-Oncology Program, which provides specialized care to protect patients’ heart health throughout cancer treatment and survivorship. Dr. Bloom is a professor in the Department of Medicine and a member of the Division...Read more
2023 28 Sep
In a recent report, published in the journal Cancer, researchers have documented a significant decline in cancer screenings and subsequent diagnoses in the United States during the initial stages of the Covid-19 pandemic. There were notable decreases in the number of newly diagnosed cases across six types of cancer including colorectal, female breast,...Read more
2023 03 Aug
Scientists at a leading U.S. hospital have reportedly made significant progress in developing a ground-breaking "cancer-killing pill" that targets solid tumours through "targeted chemotherapy." The protein was created by a research team at City of Hope, one of the largest cancer research and treatment organisations in the U.S. Known...Read more
2023 11 Jan
A team of scientists at the University of Michigan (U-M) have developed a precise 3D imaging used to measure radiation during cancer treatment. When X-rays heat tissues in the body it creates sound waves that can be captured and amplified, allowing clinicians to measure the radiation dose within the body, providing them with new data to guide...Read more
2022 10 Feb
City of Hope, one of the largest cancer research and treatment organizations in the United States has named Vince Jensen as its chief clinical operating officer. Jensen will lead clinical operations on City of Hope’s main campus in Los Angeles and throughout its network of more than 35 care locations in Southern California. He will focus on strategically...Read more
2020 31 Jan
Innovative cancer drugs take longer to pass through clinical trials, licensing and appraisal for availability on the National Health Service ( NHS) than more conventional treatments, shows a recent study published in Drug Discovery Today . You may also like: Cancer Research UK: Delays That Could Have Been Avoided In...Read more
2019 22 May
An overview of the application of personalised medicine in cardiology and the potential benefits it offers for improved cardiovascular care. The term “personalised medicine” was first introduced in the late 1990s. The Council of Advisors on Science and Technology of USA defined personalised medicine as “the tailoring of medical treatment...Read more
2015 01 Apr
Breast, colorectal and lung cancers may respond to a less-toxic class of drugs as well as they do to chemotherapy when the drugs are used in combination with fasting. The results of two new studies in mice, conducted by a multinational collaboration of researchers, have been published in the March 30 issue of Oncotarget . Starving Cancer Cells...Read more
2015 12 Feb
The high costs of healthcare are not driven by cancer patients requesting expensive tests or treatments beyond their doctor’s recommendations, according to researchers at the University of Pennsylvania. In a survey of more than 5,000 patient-physician encounters, less than 10 percent involved a patient demanding or requesting a medical intervention....Read more
2015 14 Jan
Scientists have identified a new target for future brain cancer therapies, based on a newly discovered interaction between proteins. Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center and the VCU Institute for Molecular Medicine (VIMM) observed that two genes, AEG-1 and Akt2, which are individually present in many types of cancer,...Read more
2014 30 Nov
According to a new study by researchers at the University of Michigan Comprehensive Cancer Center, clinical practice guidelines for the treatment of rectal cancer from five highly regarded organisations in the US, Europe and Canada all give different recommendations. The guidelines from the five organisations have been published within the last...Read more
2014 05 Aug
The company marketing Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU), used to treat low-risk prostate cancer, has failed to get the nod of U.S. Food and Drug Administration (FDA) on its premarket approval application. HIFU, which has been used in other countries for about 15 years, is marketed in Europe by EDAP TMS, a French...Read more
2014 08 Apr
First-generation system for testing at University Medical Center Utrecht is next step in what may be a quantum leap in tumour visualisation during radiotherapy Royal Philips and The Netherlands’ University Medical Center (UMC) have announced that the initial components of the world’s first high-field magnetic resonance imaging (MRI) guided radiation...Read more